College ter Beoordeling van Geneesmiddelen — Tekorten (CBG-MEB)

College ter Beoordeling van Geneesmiddelen — Tekorten is the official source of medicine shortage information for Netherlands (EU). Mederti checks its register daily and links every notice back to the original publication.

Official register

www.cbg-meb.nl

Country

Netherlands

Notices tracked by Mederti

2,849

Last checked

24 Sept 2026

Latest notices from CBG-MEB

• Topiramaat — active, medium, since 23 Sept 2026 (source)
• Valsartan — active, medium, since 23 Sept 2026 (source)
• Sotalol — active, medium, since 23 Sept 2026 (source)
• Amlodipine/ Valsartan — active, medium, since 23 Sept 2026 (source)
• Atovaquon/ Proguanil — active, high, since 23 Sept 2026 (source)
• Ropinirolhydroklorid — active, medium, since 23 Sept 2026 (source)
• Carbomeer/ Hyaluronzuur — active, medium, since 23 Sept 2026 (source)
• Carbomeer — active, medium, since 23 Sept 2026 (source)
• Gentamicine — active, medium, since 23 Sept 2026 (source)
• Capecitabine — active, medium, since 23 Sept 2026 (source)
• Povidone-Iodine/Lidocaine/Tetracaine 4.6%/4%/0.5% Ophthalmic — active, high, since 23 Sept 2026 (source)
• Paliperidon — active, medium, since 23 Sept 2026 (source)
• Celecoxib — active, medium, since 23 Sept 2026 (source)
• Esomeprazol — active, medium, since 23 Sept 2026 (source)
• Lacosamide — active, medium, since 23 Sept 2026 (source)

Mederti is not affiliated with or endorsed by College ter Beoordeling van Geneesmiddelen — Tekorten. All notices remain the property of their publisher and are linked to the original source.